Functional Antibody Screening With Abalone Bio's Richard Yu, Ph.D.

Update: 2025-07-30

Description

In this episode of Better Biopharma, Abalone Bio's CEO and co-founder, Richard Yu, Ph.D., explains how the company's functional antibody selection technology (FAST) platform differs from traditional affinity screening.

Follow Tyler Menichiello on LinkedIn: https://www.linkedin.com/in/tmenichiello/

Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/

Subscribe to our newsletters: https://www.bioprocessonline.com/user/edit/subscriptions

Comments

In Channel

CDMO Hunger Games And The State Of Biotech With Siren Biotechnology's Nicole Paulk, Ph.D.

2025-09-1001:00:40

Delivering Biologics To The Brain With Adaptin Bio's Michael Roberts, Ph.D., and Duke University's Mustafa Khasraw, MD

2025-08-2736:11

Developing An In Vivo CAR-T With Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D.

2025-08-1348:39

Functional Antibody Screening With Abalone Bio's Richard Yu, Ph.D.

2025-07-3043:45

Using Algae To Manufacture Oral Biologics With Lumen Bioscience's Craig Behnke, Ph.D.

2025-07-1644:34

PILOT: Introducing Better Biopharma

2025-07-1602:45

00:00

Functional Antibody Screening With Abalone Bio's Richard Yu, Ph.D.

#box-pro-ellipsis-175751553504279{-webkit-line-clamp:2;}Functional Antibody Screening With Abalone Bio's Richard Yu, Ph.D.

Functional Antibody Screening With Abalone Bio's Richard Yu, Ph.D.

Tyler Menichiello

Functional Antibody Screening With Abalone Bio's Richard Yu, Ph.D.